BRPI0016231B8 - composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivo - Google Patents
composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivoInfo
- Publication number
- BRPI0016231B8 BRPI0016231B8 BRPI0016231A BR0016231A BRPI0016231B8 BR PI0016231 B8 BRPI0016231 B8 BR PI0016231B8 BR PI0016231 A BRPI0016231 A BR PI0016231A BR 0016231 A BR0016231 A BR 0016231A BR PI0016231 B8 BRPI0016231 B8 BR PI0016231B8
- Authority
- BR
- Brazil
- Prior art keywords
- digestive tract
- ameliorating
- risks
- compositions
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
"composição compreendendo enzima com capacidade de clivar uma ligação que efetua a liberação de uma proteína ou carboidrato de superfície celular para ser usada no tratamento de infecções". enzimas de uma classe particular, caracterizadas pela capacidade de clivar uma ligação que efetua a liberação de uma proteína ou carboidrato de superfície celular, que não contêm um agente antiinfecção, apresentam significativa atividade antiinfecciosa. sob administração oral, essas enzimas são eficazes, por exemplo, no tratamento de infecções do trato digestivo em humanos e em animais. posteriormente, há benefícios de uma taxa de crescimento, eficácia de alimento, e saúde gerais significativamente aumentadas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16993599P | 1999-12-10 | 1999-12-10 | |
PCT/US2000/033466 WO2001041785A2 (en) | 1999-12-10 | 2000-12-08 | Enzyme treatment for infection |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0016231A BR0016231A (pt) | 2003-06-24 |
BRPI0016231B1 BRPI0016231B1 (pt) | 2016-10-04 |
BRPI0016231B8 true BRPI0016231B8 (pt) | 2021-05-25 |
Family
ID=22617824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0016231A BRPI0016231B8 (pt) | 1999-12-10 | 2000-12-08 | composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivo |
Country Status (31)
Country | Link |
---|---|
US (2) | US6780628B2 (pt) |
EP (1) | EP1239872B1 (pt) |
JP (1) | JP4871473B2 (pt) |
KR (1) | KR100639746B1 (pt) |
CN (3) | CN1433319A (pt) |
AR (2) | AR026764A1 (pt) |
AT (1) | ATE481981T1 (pt) |
AU (1) | AU782831B2 (pt) |
BR (1) | BRPI0016231B8 (pt) |
CA (1) | CA2394856C (pt) |
CL (1) | CL2008000057A1 (pt) |
CO (1) | CO5280226A1 (pt) |
CR (1) | CR6674A (pt) |
CZ (1) | CZ304925B6 (pt) |
DE (1) | DE60045010D1 (pt) |
DK (1) | DK1239872T3 (pt) |
ES (1) | ES2353371T3 (pt) |
HU (1) | HU230301B1 (pt) |
IL (2) | IL150048A0 (pt) |
IN (1) | IN247731B (pt) |
MX (1) | MX264033B (pt) |
MY (1) | MY124714A (pt) |
NZ (1) | NZ519404A (pt) |
PH (1) | PH12000003381B1 (pt) |
PL (1) | PL203054B1 (pt) |
PT (1) | PT1239872E (pt) |
RU (1) | RU2272419C2 (pt) |
SK (1) | SK287956B6 (pt) |
TW (1) | TWI255189B (pt) |
UA (1) | UA78486C2 (pt) |
WO (1) | WO2001041785A2 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78486C2 (uk) | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти) |
US7247299B2 (en) * | 2002-11-27 | 2007-07-24 | Kemin Industries, Inc. | Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens |
US8703134B2 (en) | 2003-05-15 | 2014-04-22 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US8394379B2 (en) * | 2003-05-15 | 2013-03-12 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US20050014932A1 (en) * | 2003-05-15 | 2005-01-20 | Iogenetics, Llc | Targeted biocides |
US7566447B2 (en) * | 2003-05-15 | 2009-07-28 | Iogenetics, Llc | Biocides |
US8710012B2 (en) | 2003-07-14 | 2014-04-29 | Cls Therapeutics Limited | Method for treating oncological diseases |
US8431123B2 (en) | 2003-07-14 | 2013-04-30 | Cls Therapeutics Limited | Method for treating systemic bacterial, fungal and protozoan infection |
US8388951B2 (en) | 2003-07-14 | 2013-03-05 | Cls Therapeutics Limited | Method for treating systemic DNA mutation disease |
AU2005332655A1 (en) * | 2004-10-20 | 2006-12-14 | Iogenetics, Llc | Biocides |
US8916151B2 (en) | 2005-04-25 | 2014-12-23 | Cls Therapeutics Limited | Method for treating a reduction of fertility |
SI1973561T1 (sl) | 2005-12-15 | 2011-07-29 | Chemgen Corp | Encimi, ki zmanjĺ ujejo imunski stres |
PL2095825T3 (pl) | 2006-11-28 | 2011-12-30 | Cls Therapeutics Ltd | Sposób leczenia ludzkich chorób związanych ze zwiększoną zawartością kwasu deoksyrybonukleinowego w przestrzeniach pozakomórkowych i tkankach i preparat leczniczy do przeprowadzenia tego sposobu |
HUE025717T2 (en) * | 2007-06-08 | 2016-04-28 | Australian Poultry Crc Pty Ltd | Clostridium NetB toxin |
BRPI0820818A2 (pt) * | 2007-12-20 | 2015-06-16 | Danisco Us Inc | Controle e prevenção enzimática de biofilme |
DK2254591T3 (da) * | 2008-02-08 | 2017-11-06 | Prothera Inc | Inhibering eller behandling af gastrointestinal biofilm |
PT2814331T (pt) | 2012-02-16 | 2019-02-12 | Elanco Us Inc | Métodos e composições para redução do impacto ambiental de resíduos animais |
US10617743B2 (en) | 2014-06-19 | 2020-04-14 | Cls Therapeutics Limited | Method to improve safety and efficacy of anti-cancer therapy |
TWI656872B (zh) | 2014-11-13 | 2019-04-21 | 美商益農美國公司 | 甲基鹽黴素於豬飼料中之抗病毒效果 |
EP3297657B1 (en) | 2015-05-22 | 2020-03-25 | GENKIN, Dmitry Dmitrievich | Extracellular dna as a therapeutic target in neurodegeneration |
CN106119221A (zh) * | 2016-06-28 | 2016-11-16 | 浙江省农业科学院 | 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用 |
CN106318925B (zh) * | 2016-08-19 | 2021-04-02 | 浙江省农业科学院 | 利用枯草芽孢杆菌高效表达pi-plc基因的方法 |
CN106615691B (zh) * | 2016-10-11 | 2019-07-02 | 上海国龙生物技术集团有限公司 | 一种抗感染酶复合剂及其在饲料中的应用 |
US10501730B2 (en) * | 2017-05-30 | 2019-12-10 | Ab Enzymes Oy | Mannanase variants |
EP3740581A4 (en) | 2018-01-16 | 2021-10-27 | CLS Therapeutics Limited | TREATMENT OF DISEASES BY LIVER EXPRESSION OF AN ENZYME WITH DESOXYRIBONUCLEASE (DNASE) ACTIVITY |
MX2020009045A (es) * | 2018-03-02 | 2020-10-12 | Evonik Operations Gmbh | Procedimiento in vitro para detectar disfuncion de la barrera intestinal en animales mediante la determinacion de ovotransferrina. |
RU2720471C1 (ru) * | 2019-03-21 | 2020-04-30 | Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" | Кормовая добавка для цыплят-бройлеров |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1509866A (en) | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
JPS5534039A (en) | 1978-08-30 | 1980-03-10 | Hiroo Ikezawa | Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis |
WO1987000196A1 (en) | 1985-07-09 | 1987-01-15 | Quadrant Bioresources Limited | Protection of proteins and the like |
US5049379A (en) | 1987-07-27 | 1991-09-17 | Wisconsin Alumni Research Foundation | Fungicidal toxin and method and inoculum for controlling root rot and damping off |
US4877738A (en) | 1986-07-25 | 1989-10-31 | Wisconsin Alumni Research Foundation | Biological control of damping off and root rot and inoculum preparation therefor |
JPH0338530A (ja) * | 1989-07-03 | 1991-02-19 | Ajinomoto Co Inc | 抗真菌剤 |
US5487897A (en) * | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
DK0531437T3 (da) * | 1990-05-29 | 1998-08-31 | Chemgen Corp | Hemicellulasetilskud med henblik på at forbedre energiudnyttelsen af hemicelluloseholdige levnedsmidler og dyrefoder |
EP0477739A3 (en) | 1990-09-27 | 1992-12-09 | F. Hoffmann-La Roche Ag | Glycosyl-phosphatidylinositol-specific phospholipase d |
JPH07184642A (ja) * | 1993-12-27 | 1995-07-25 | Toagosei Co Ltd | ホスホリパーゼcの生産方法 |
MY134684A (en) * | 1995-05-15 | 2007-12-31 | Gist Brocades Bv | Application of phospholipases in animal feed |
EP0743017B1 (en) * | 1995-05-15 | 2004-09-29 | DSM IP Assets B.V. | Application of phospholipases in animal feed |
JPH08332032A (ja) * | 1995-06-12 | 1996-12-17 | Showa Denko Kk | 動物経口物用酵素剤及びその用途 |
JP3914585B2 (ja) * | 1995-10-19 | 2007-05-16 | イーエヌ大塚製薬株式会社 | マクロファージ一酸化窒素産生亢進剤 |
CN1092495C (zh) * | 1996-05-03 | 2002-10-16 | 开姆根有限公司 | 半纤维素酶在低热焓饲料中的应用 |
US6162473A (en) * | 1996-05-03 | 2000-12-19 | Chemgen Corporation | Hemicellulase use in feeds with low caloric content |
JPH1045581A (ja) * | 1996-07-29 | 1998-02-17 | Hideyo Yamaguchi | 好中球機能低下抑制剤又は感染防御剤 |
WO1998018912A1 (en) * | 1996-10-31 | 1998-05-07 | Novo Nordisk A/S | Novel phospholipase, production and use thereof |
AU753232B2 (en) | 1998-10-15 | 2002-10-10 | Dsm N.V. | Antimicrobial enzymes in animal feed |
UA78486C2 (uk) | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти) |
US20020116028A1 (en) * | 2001-02-20 | 2002-08-22 | Wilson Greatbatch | MRI-compatible pacemaker with pulse carrying photonic catheter providing VOO functionality |
-
2000
- 2000-08-12 UA UA2002075677A patent/UA78486C2/uk unknown
- 2000-12-07 CO CO00093684A patent/CO5280226A1/es not_active Application Discontinuation
- 2000-12-07 AR ARP000106541A patent/AR026764A1/es not_active Application Discontinuation
- 2000-12-08 DE DE60045010T patent/DE60045010D1/de not_active Expired - Lifetime
- 2000-12-08 JP JP2001543129A patent/JP4871473B2/ja not_active Expired - Lifetime
- 2000-12-08 AU AU25776/01A patent/AU782831B2/en not_active Expired
- 2000-12-08 PT PT00989240T patent/PT1239872E/pt unknown
- 2000-12-08 PL PL356175A patent/PL203054B1/pl unknown
- 2000-12-08 CZ CZ2002-2007A patent/CZ304925B6/cs not_active IP Right Cessation
- 2000-12-08 MY MYPI20005779A patent/MY124714A/en unknown
- 2000-12-08 CN CN00818851A patent/CN1433319A/zh active Pending
- 2000-12-08 CN CNA2008101259037A patent/CN101327320A/zh active Pending
- 2000-12-08 NZ NZ519404A patent/NZ519404A/en not_active IP Right Cessation
- 2000-12-08 CA CA2394856A patent/CA2394856C/en not_active Expired - Lifetime
- 2000-12-08 DK DK00989240.7T patent/DK1239872T3/da active
- 2000-12-08 IL IL15004800A patent/IL150048A0/xx unknown
- 2000-12-08 PH PH12000003381A patent/PH12000003381B1/en unknown
- 2000-12-08 WO PCT/US2000/033466 patent/WO2001041785A2/en not_active Application Discontinuation
- 2000-12-08 MX MXPA02005735 patent/MX264033B/es active IP Right Grant
- 2000-12-08 CN CN201110076924.6A patent/CN102172262B/zh not_active Expired - Lifetime
- 2000-12-08 RU RU2002118694/13A patent/RU2272419C2/ru active
- 2000-12-08 KR KR1020027007363A patent/KR100639746B1/ko active IP Right Review Request
- 2000-12-08 SK SK826-2002A patent/SK287956B6/sk not_active IP Right Cessation
- 2000-12-08 BR BRPI0016231A patent/BRPI0016231B8/pt not_active IP Right Cessation
- 2000-12-08 US US09/731,971 patent/US6780628B2/en not_active Expired - Lifetime
- 2000-12-08 ES ES00989240T patent/ES2353371T3/es not_active Expired - Lifetime
- 2000-12-08 EP EP00989240A patent/EP1239872B1/en not_active Expired - Lifetime
- 2000-12-08 HU HU0203402A patent/HU230301B1/hu unknown
- 2000-12-08 AT AT00989240T patent/ATE481981T1/de active
-
2001
- 2001-03-07 TW TW089126252A patent/TWI255189B/zh not_active IP Right Cessation
-
2002
- 2002-06-05 IL IL150048A patent/IL150048A/en active IP Right Grant
- 2002-06-06 IN IN585DE2002 patent/IN247731B/en unknown
- 2002-06-07 CR CR6674A patent/CR6674A/es unknown
-
2004
- 2004-05-28 US US10/855,416 patent/US7723091B2/en not_active Expired - Lifetime
-
2008
- 2008-01-09 CL CL200800057A patent/CL2008000057A1/es unknown
-
2013
- 2013-01-24 AR ARP130100218A patent/AR089799A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0016231B8 (pt) | composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivo | |
BR0007166A (pt) | Método para aumentar a atividade dos animais de estimação | |
DE69915458D1 (de) | Dextran formulierungen zur behandlung entzündlicher gelenkerkrankungen | |
DE69533593D1 (de) | Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten. | |
MXPA05000880A (es) | Probioticos para funciones neuromusculares del intestino. | |
BR0013010A (pt) | Formulação de cloreto de sódio de moxifloxacina | |
BR0314511A (pt) | Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater | |
DK0671942T3 (da) | Farmaceutisk præparat omfattende en beta-lactamantibiotikumnedbrydende forbindelse og anvendelse deraf | |
TR200400363T4 (tr) | Antibiyotikten / Antibiyotiklerden oluşan bir preparatın imalatı ve kullanımı | |
DE60122672D1 (de) | Zusammensetzung zur intestinalen verabreichung | |
IS2742B (is) | Samsetning@sem@nær@yfir@basískan@svingómýelínasa@af@bakteríuuppruna@til@nota@sem@næringarfræðileg@efnablanda@@fæðubótarefni@eða@lyfjaafurð | |
CA2322878A1 (en) | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage | |
BR9811548A (pt) | Secreções maternas imunes e seu uso no tratamento e/ou profilaxia de condições do corpo humano | |
AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
WO1999012552A8 (en) | 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS | |
BR9908143A (pt) | Composições para a redução da atividade enzimática, utilização de ácido dissuccìnico de etileno diamina, utilização de um agente de complexação, artigo absorvente, desodorante, e utilização de composição | |
CA2301872A1 (en) | 8a-azalides as veterinary antimicrobial agents | |
DE69941459D1 (de) | Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen | |
BR0308734A (pt) | Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção | |
DE69330809T2 (de) | Therapeutisches Agens für Neutropenie | |
TH54151A (th) | องค์ประกอบซึ่งประกอบรวมด้วยเอนไซม์สำหรับรักษาการติดเชื้อของทางเดินอาหาร | |
TH54151B (th) | การรักษาการติดเชื้อด้วยเอนไซม์ | |
Pellegrin et al. | Response to infection in patients with acute leukemia during remission induction treatment: Ceftazidime versus cefotaxime+ tobramycin. | |
IL110888A0 (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative | |
Holland et al. | The cutaneous propionibacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: ELI LILLY AND COMPANY (US) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/10/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/12/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 08/12/2020 |